Hepatitis B: Clinical Trials

9 trials for Hepatitis B, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

9 terminated. 9 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 49Terminated 9

Follow Hepatitis B: new trials by email Literature Review of Hepatitis B trials Research Report on Hepatitis B

Trials (filtered) newest first · largest first

All 9 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
HBV Vaccination of Healthy Volunteers to Evaluate the Composition of Germinal Centers
Hepatitis B Vaccine (Recombinant) - Hepatitis B
Phase 4TerminatedRockefeller University92022-12-102026-04-16
Utilization and Efficacy of Tenofovir DF in Adolescents With Chronic Hepatitis B Virus Infection
Tenofovir DF, DEXA Scan - Hepatitis B
Phase 4TerminatedGilead Sciences302015-07-032019-05-20
Comparison Between Lamivudine and Entecavir Treatment in Spontaneous Severe Acute Exacerbation
Lamivudine, Entecavir - Chronic Hepatitis B
Phase 4TerminatedTaichung Veterans General Hospital172012-07-012016-10-18
Induction of Fibrosis Regression on Patients With Chronic Hepatitis B Infection
Treatment with entecavir(Baraclude®) - Hepatitis B, Chronic, Liver Fibrosis
Phase 4TerminatedRWTH Aachen University72011-04-012015-09-23
A Study to Evaluate the Efficacy and the Change of sAg Levels in Chronic Hepatitis B Patients Receiving Clevudine Treatment Over the Long Period
Clevudine - Chronic Hepatitis B
Phase 4TerminatedBukwang Pharmaceutical2002009-11-012015-07-22
A Study With Clevudine Monotherapy or Adefovir and Clevudine Combination in Patients With Chronic Hepatitis B
Clevudine, Adefovir - Chronic Hepatitis B
Phase 4TerminatedBukwang Pharmaceutical2002009-09-012014-12-18
A Study to Compare and Evaluate Intrahepatic cccDNA Reduction After Administrating Clevudine or Entecavir in the Chronic HBV Patients
Clevudine, Entecavir - Chronic Hepatitis B
Phase 4TerminatedBukwang Pharmaceutical752009-08-012014-12-18
Efficacy of Clevudine Plus Lamivudine for Lamivudine-resistant Chronic Hepatitis B Patients
adefovir, clevudine, lamivudine - Chronic Hepatitis B
Phase 4TerminatedInje University302008-12-012011-06-23
A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Patients With Lamivudine Resistant HBeAg-Negative Chronic Hepatitis B.
peginterferon alfa-2a (40KD) [PEGASYS] - Hepatitis B, Chronic
Phase 4TerminatedHoffmann-La Roche602007-09-012008-06-30

Narrower conditions

Hepatitis B, Chronic (7)  ·  Liver Cirrhosis (1)

Broader conditions

Blood-Borne Infections (9)  ·  Communicable Diseases (9)  ·  DNA Virus Infections (9)  ·  Digestive System Diseases (9)  ·  Hepadnaviridae Infections (9)  ·  Hepatitis (9)  ·  Hepatitis, Viral, Human (9)  ·  Infections (9)  ·  Liver Diseases (9)  ·  Virus Diseases (9)  ·  Chronic Disease (7)  ·  Disease Attributes (7)  ·  Hepatitis, Chronic (7)  ·  Pathologic Processes (7)

Interventions

clevudine (4)  ·  Lamivudine (2)  ·  adefovir (2)  ·  entecavir (2)  ·  Absorptiometry, Photon (1)  ·  Hepatitis B Vaccines (1)  ·  Tenofovir (1)  ·  Therapeutics (1)  ·  adefovir dipivoxil (1)  ·  peginterferon alfa-2a (1)

Sponsors

Bukwang Pharmaceutical (3)  ·  Gilead Sciences (1)  ·  Hoffmann-La Roche (1)  ·  Inje University (1)  ·  RWTH Aachen University (1)  ·  Rockefeller University (1)  ·  Taichung Veterans General Hospital (1)

Countries

South Korea (4)  ·  Belgium (1)  ·  France (1)  ·  Germany (1)  ·  Greece (1)  ·  Italy (1)  ·  Romania (1)  ·  Spain (1)  ·  Taiwan (1)  ·  Turkey (Türkiye) (1)  ·  United Kingdom (1)  ·  United States (1)

Top investigators

Chi-Yi Chen, M.D. (1)  ·  Christian Trautwein, Professor MD (1)  ·  Chun-Che Lin, M.D. (1)  ·  Gabriel D. Victora, PhD (1)  ·  Hsueh-Chou Lai, M.D. (1)  ·  Jen-Chieh Huang, M.D. (1)  ·  June Sung Lee, M.D. (1)  ·  Sheng-Shun Yang, M.D. (1)  ·  Shih-Jer Hsu, M.D. (1)  ·  Tsung-Ming Chen, M.D. (1)  ·  Yu-Chun Hsu, M.D. (1)

Results publications

PMID 28671553

NIH funding

2014 (1)